Back

Metabolic improvement without structural reverse remodelling in diabetic atrial fibrillation patients receiving lifestyle modification: A post-hoc analysis of the PRAGUE-25 trial

29 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: metabolic and mechanistic insights Prevalence and Incidence of Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jan Alexander Mohr

AGEL Hospital Trinec Podlesi, Trinec (Czechia)

6 More presentations in this session

Presentation thumbnail
Sex-specific FIND-AF risk thresholds aligned with CMR-defined atrial cardiomyopathy identify excess cardiovascular risk in heart failure across nationwide primary care data
Doctor K. Kazi (Manchester, GB)
Abstract
Presentation thumbnail
Gut microbiota-derived isovaleric acid alleviates atrial fibrillation by suppressing GSDME-dependent pyroptosis
Doctor N. Ding (Xi'an, CN)
Abstract
Presentation thumbnail
Influence of AF burden on NT-proBNP and left ventricular reverse remodeling in patients with AF and HF: catheter ablation versus pharmacological rhythm control
Doctor B. Orazlyyeva (Ashgabat, TM)
Abstract
Presentation thumbnail
Symptoms and quality of life in individuals with screen-detected atrial fibrillation: insights from the NORSCREEN trial
Mr M. Boskovic (Kristiansand, NO)
Abstract
Presentation thumbnail
Association of diabetes, glycemic status and vascular brain lesions in patients with atrial fibrillation
Ms S. Balasundaram (Basel, CH)
Abstract

Access the full session

Session thumbnail
Atrial fibrillation: metabolic and mechanistic insights

The Event

Event poster

ESC Congress 2026

29 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Diabetes mellitus and atrial fibrillation-the burden of pur century?
2 March 2019
thumbnail
Congress Presentation
Cardiac reverse remodeling in real life, a therapeuthic objective.
22 May 2023
thumbnail
Congress Presentation
Atrial fibrillation burden and clinical outcomes in catheter ablation vs lifestyle modification: prague-25 sub-analysis
12 April 2026
thumbnail
Congress Presentation
Echocardiographic and metabolic correlates of NT-proBNP in patients with severe obesity
13 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources